Takeda Pharmaceutical (TAK) Current Taxes: 2018-2025
Historic Current Taxes for Takeda Pharmaceutical (TAK) over the last 8 years, with Mar 2025 value amounting to $875.0 million.
- Takeda Pharmaceutical's Current Taxes rose 17.99% to $875.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $875.0 million, marking a year-over-year increase of 17.99%. This contributed to the annual value of $876.4 million for FY2025, which is 15.00% up from last year.
- Per Takeda Pharmaceutical's latest filing, its Current Taxes stood at $875.0 million for Q1 2025, which was up 17.99% from $741.6 million recorded in Q1 2024.
- In the past 5 years, Takeda Pharmaceutical's Current Taxes ranged from a high of $1.8 billion in Q1 2023 and a low of $741.6 million during Q1 2024.
- Moreover, its 3-year median value for Current Taxes was $875.0 million (2025), whereas its average is $1.1 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Current Taxes grew by 26.03% in 2022, and later tumbled by 57.78% in 2024.
- Takeda Pharmaceutical's Current Taxes (MRQ) stood at $1.4 billion in 2021, then increased by 26.03% to $1.7 billion in 2022, then rose by 1.61% to $1.8 billion in 2023, then plummeted by 57.78% to $741.6 million in 2024, then grew by 17.99% to $875.0 million in 2025.
- Its Current Taxes was $875.0 million in Q1 2025, compared to $741.6 million in Q1 2024 and $1.8 billion in Q1 2023.